Results 1 to 10 of about 70 (68)
Some of the next articles are maybe not open access.
Disparities in liver cancer occurrence in the United States by race/ethnicity and state
Ca-A Cancer Journal for Clinicians, 2017Farhad Islami +2 more
exaly
Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia
Ca-A Cancer Journal for Clinicians, 2006exaly
Recent progress in the diagnosis and treatment of ovarian cancer
Ca-A Cancer Journal for Clinicians, 2011exaly
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
Ca-A Cancer Journal for Clinicians, 2006exaly
Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator [PDF]
Blood, 1977 Abstract This study was prompted by the observation that fresh platelet suspensions--prepared by gel filtration or albumin density gradient centrifugation--possessed only minimal factor V activity, whereas frozen-and-thawed platelet suspensions possessed striking factor V activity.
Samuel I. Rapaport +5 more
openaire +4 more sources
Molecular Pharmacology, 2009 Platelet-activating factor (PAF) is a potent, bioactive phospholipid that acts on multiple cells and tissues through its G protein-coupled receptor (GPCR). PAF is not stored but is rapidly generated via enzymatic acetylation of the precursor 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphocholine (lysoPAF). The bioactivity of PAF is effectively and tightly
Zhenyu Li +9 more
openaire +4 more sources